Pathological and physiological functions of presenilins

Mutations in PSEN1 and PSEN2 genes account for the majority of cases of early-onset familial Alzheimer disease. Since the first prediction of a genetic link between PSEN1 and PSEN2 with Alzheimer's disease, many research groups from both academia and pharmaceutical industry have sought to unrav...

Full description

Bibliographic Details
Main Authors: Vetrivel, Kulandaivelu S, Zhang, Yun-wu, Xu, Huaxi, Thinakaran, Gopal
Format: Online
Language:English
Published: BioMed Central 2006
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1513131/
id pubmed-1513131
recordtype oai_dc
spelling pubmed-15131312006-07-20 Pathological and physiological functions of presenilins Vetrivel, Kulandaivelu S Zhang, Yun-wu Xu, Huaxi Thinakaran, Gopal Review Mutations in PSEN1 and PSEN2 genes account for the majority of cases of early-onset familial Alzheimer disease. Since the first prediction of a genetic link between PSEN1 and PSEN2 with Alzheimer's disease, many research groups from both academia and pharmaceutical industry have sought to unravel how pathogenic mutations in PSEN cause presenile dementia. PSEN genes encode polytopic membrane proteins termed presenilins (PS1 and PS2), which function as the catalytic subunit of γ-secretase, an intramembrane protease that has a wide spectrum of type I membrane protein substrates. Sequential cleavage of amyloid precursor protein by BACE and γ-secretase releases highly fibrillogenic β-amyloid peptides, which accumulate in the brains of aged individuals and patients with Alzheimer's disease. Familial Alzheimer's disease-associated presenilin variants are thought to exert their pathogenic function by selectively elevating the levels of highly amyloidogenic Aβ42 peptides. In addition to Alzheimer's disease, several recent studies have linked PSEN1 to familiar frontotemporal dementia. Here, we review the biology of PS1, its role in γ-secretase activity, and discuss recent developments in the cell biology of PS1 with respect to Alzheimer's disease pathogenesis. BioMed Central 2006-06-12 /pmc/articles/PMC1513131/ /pubmed/16930451 http://dx.doi.org/10.1186/1750-1326-1-4 Text en Copyright © 2006 Vetrivel et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Vetrivel, Kulandaivelu S
Zhang, Yun-wu
Xu, Huaxi
Thinakaran, Gopal
spellingShingle Vetrivel, Kulandaivelu S
Zhang, Yun-wu
Xu, Huaxi
Thinakaran, Gopal
Pathological and physiological functions of presenilins
author_facet Vetrivel, Kulandaivelu S
Zhang, Yun-wu
Xu, Huaxi
Thinakaran, Gopal
author_sort Vetrivel, Kulandaivelu S
title Pathological and physiological functions of presenilins
title_short Pathological and physiological functions of presenilins
title_full Pathological and physiological functions of presenilins
title_fullStr Pathological and physiological functions of presenilins
title_full_unstemmed Pathological and physiological functions of presenilins
title_sort pathological and physiological functions of presenilins
description Mutations in PSEN1 and PSEN2 genes account for the majority of cases of early-onset familial Alzheimer disease. Since the first prediction of a genetic link between PSEN1 and PSEN2 with Alzheimer's disease, many research groups from both academia and pharmaceutical industry have sought to unravel how pathogenic mutations in PSEN cause presenile dementia. PSEN genes encode polytopic membrane proteins termed presenilins (PS1 and PS2), which function as the catalytic subunit of γ-secretase, an intramembrane protease that has a wide spectrum of type I membrane protein substrates. Sequential cleavage of amyloid precursor protein by BACE and γ-secretase releases highly fibrillogenic β-amyloid peptides, which accumulate in the brains of aged individuals and patients with Alzheimer's disease. Familial Alzheimer's disease-associated presenilin variants are thought to exert their pathogenic function by selectively elevating the levels of highly amyloidogenic Aβ42 peptides. In addition to Alzheimer's disease, several recent studies have linked PSEN1 to familiar frontotemporal dementia. Here, we review the biology of PS1, its role in γ-secretase activity, and discuss recent developments in the cell biology of PS1 with respect to Alzheimer's disease pathogenesis.
publisher BioMed Central
publishDate 2006
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1513131/
_version_ 1611384678602768384